Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system

Results from the EMN-011 trial, combination therapy for multiple myeloma

Maintenance therapy with the oral PI ixazomib significantly prolongs PFS following ASCT in multiple myeloma

Efficacy and safety of KRd or KCd induction in multiple myeloma

Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL

Clinical impact of an accurate genetic characterisation of older AML patients

Accelerated partial breast irradiation not equivalent to whole breast irradiation

Circulating tumour-cell count used to decide between treatments for breast cancer patients

Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer

Low-dose tamoxifen reduces recurrence and new breast disease

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients